A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs

被引:307
作者
Kotarsky, K [1 ]
Nilsson, NE [1 ]
Flodgren, E [1 ]
Owman, C [1 ]
Olde, B [1 ]
机构
[1] Wallenberg Neurosci Ctr, Div Mol Neurobiol, SE-22184 Lund, Sweden
关键词
receptor; cell surface; GPR40; fatty acid; thiazolidinediones; diabetes; obesity; arteriosclerosis; reverse pharmacology; drug evaluation; preclinical;
D O I
10.1016/S0006-291X(02)03064-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acids, which are essential nutritional components, are also involved in cardiovascular and metabolic diseases. Here we report a human cell surface receptor that we name free fatty acid receptor (FFAR), because it is specifically activated by medium to long-chain free fatty acids. The receptor belongs to the class of seven-transmembrane, G-protein coupled receptors (GPCRs) and also mediates responses to antidiabetic drugs of the thiazolidinedione type. It is expressed in skeletal muscle, heart, liver, and pancreatic beta-cells. Stimulation of FFAR increases the intracellular calcium concentration in cells expressing the receptor in a native (pancreatic beta-cell line) or in a recombinant form. In view of the nature of the activating substances, their physiological role in the body, and the tissue distribution of FFAR we suggest the term "nutrient sensing receptor" for receptors acting at the interface between dietary components and signalling molecules. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:406 / 410
页数:5
相关论文
共 32 条
[11]   Prostaglandins and leukotrienes: Advances in eicosanoid biology [J].
Funk, CD .
SCIENCE, 2001, 294 (5548) :1871-1875
[12]   Pioglitazone ameliorates tumor necrosis factor-α-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ [J].
Iwata, M ;
Haruta, T ;
Usui, I ;
Takata, Y ;
Takano, A ;
Uno, T ;
Kawahara, J ;
Ueno, E ;
Sasaoka, T ;
Ishibashi, O ;
Kobayashi, M .
DIABETES, 2001, 50 (05) :1083-1092
[13]   Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients [J].
Jira, W ;
Spiteller, G ;
Carson, W ;
Schramm, A .
CHEMISTRY AND PHYSICS OF LIPIDS, 1998, 91 (01) :1-11
[14]   Drug efficacy at G protein-coupled receptors [J].
Kenakin, T .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :349-379
[15]   A chimeric reporter gene allowing for clone selection and high-throughput screening of reporter cell lines expressing G-protein-coupled receptors [J].
Kotarsky, K ;
Owman, C ;
Olde, B .
ANALYTICAL BIOCHEMISTRY, 2001, 288 (02) :209-215
[16]   AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA) [J].
LEHMANN, JM ;
MOORE, LB ;
SMITHOLIVER, TA ;
WILKISON, WO ;
WILLSON, TM ;
KLIEWER, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12953-12956
[17]  
Linder M., 1991, Nutritional Biochemistry and Metabolism, V2nd ed.
[18]   Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor α (PPARα)-independent pathway [J].
Louet, JF ;
Chatelain, F ;
Decaux, JF ;
Park, EA ;
Kohl, C ;
Pineau, T ;
Girard, J ;
Pegorier, JP .
BIOCHEMICAL JOURNAL, 2001, 354 :189-197
[19]   Biological complexity is under the 'strange attraction' of non-esterified fatty acids [J].
Nunez, EA .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1997, 57 (01) :107-110
[20]   Cloning of cDNA encoding a putative chemoattractant receptor [J].
Owman, C ;
Nilsson, C ;
Lolait, SJ .
GENOMICS, 1996, 37 (02) :187-194